Dostarlimab and Cobolimab in Advanced Cervical Cancer

Clinical trial NCT06238635 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06238635
Sponsor: Meghan Shea
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Advanced Cervical Carcinoma Metastatic Cervical Cancer Metastatic Cervical Carcinoma Recurrent Cervical Carcinoma

Start date: 2024-03-11
Primary completion: 2026-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.